This site is intended for Healthcare Professionals only.

Levomepromazine 25mg/1ml solution for injection faces supply disruption

Date:

Share post:

Levomepromazine 25mg/1ml solution for injection will remain unavailable until the week commencing March 7,2022, Department of Health and Social Care (DHSC) said in an update.

While alternative medicines for use in palliative care remain available in ample supply to support an uplift in demand, the date supply resumption of Levomepromazine is yet to be confirmed.

The DHSC has sent a copy of this medicine supply notification to all pharmacy NHS email addresses.

It further informed primary care providers that prescription validation has been temporarily implemented at wholesaler level.

To ensure continuity of supply to patients, the department has advised community pharmacists to work with their local hospitals and request mutual aid if wholesaler supplies are exhausted.

In case pharmacists are not able to secure supplies via mutual aid, they should work with specialist palliative care teams to use alternative medication, the DHSC stated.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue June 2024

Related articles

FIP supports PDA’s Safer Pharmacies Charter

PDA urges all UK pharmacists to take part in the 2024 Safer Pharmacies Survey The International Pharmaceutical Federation...

Topiramate should not be prescribed for epilepsy during pregnancy unless…

MHRA tightens safety measures for topiramate by introducing a new pregnancy prevention programme  Healthcare professionals in the UK are...

WHO issues alert on fake copies of Novo Nordisk’s diabetes drug Ozempic

Falsified batches of Ozempic (semaglutide) were detected in Brazil, the UK, Northern Ireland and the United States The...

Synnovis cyber attack: NHS patient data leaked, services impacted

The NHS has set up helpline number to answer queries and concerns about patient data as Synnovis cyber...